MORE►
Orano Med
Orano Med facility in Plano [Photo: Orano Med]
Plano-Based Orano Med to Collaborate with U.K. Company on Novel Cancer Therapies
by Lance Murray | Sep 12, 2023
“Since the inception of Orano Med, we've recognized the value of collaboration,” Orano Med CEO Julien Dodet said. “In our strategy to develop and deliver 212Pb Targeted Alpha Therapy for cancer patients, we’re delighted to work with Orbit Discovery and leverage its technology and expertise in peptide ligand discovery to build our pipeline of radiotherapies.”
by Dallas Innovates | Staff Report |
Jul 14, 2023
A holder of 34 patents, Sherry was a pioneer in designing molecular materials for use in medical imaging. His work on chemicals called macrocyclic ligands led to their use in carrying "a payload of metallic radiotherapeutic compounds that can kill cancer cells on contact, while the outside molecular structure can be designed to bind to a specific protein that ensures precise delivery to only diseased tissue," Amanda Siegfried writes in UT Dallas Magazine.
MORE►
